Gyre Therapeutics, Inc. GYRE GNI — Other Liabilities
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilities.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gni — other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s GNI — other liabilities?
- Gyre Therapeutics, Inc. (GYRE) reported GNI — other liabilities of $200K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s GNI — other liabilities changed year-over-year?
- Gyre Therapeutics, Inc.'s GNI — other liabilities decreased by 0.0% year-over-year, from $200K to $200K.
- What does GNI — other liabilities mean?
- Includes miscellaneous obligations and debts associated with the GNI segment that do not fall under standard liability categories. This reflects the segment's non-core financial commitments and potential future cash outflows. Tracking these liabilities is essential for understanding the segment's overall risk profile and long-term financial obligations.